MAXCYTE INC (MXCT) Stock Income Statement
NASDAQ:MXCT - Nasdaq - US57777K1060 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 37.68M | 38.63M | 41.29M | 44.26M | 33.89M | |||
| Cost Of Goods | 7.19M | 7.10M | 4.74M | 5.10M | 3.65M | |||
| Gross Profit | 30.48M | 31.53M | 36.55M | 39.16M | 30.25M | |||
| Operating Expenses | 80.78M | 82.72M | 84.84M | 66.52M | 48.43M | |||
| Research and Development | 21.45M | 22.23M | 23.82M | 19.51M | 15.41M | |||
| Selling, General, and Administrative Expenses | 55.20M | 56.35M | 57.04M | 44.48M | 31.68M | |||
| Operating Income | -50.30M | -51.20M | -48.30M | -27.36M | -18.19M | |||
| Interest Income/Expense | 9.43M | 10.14M | 10.38M | 3.79M | -890.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -41.79M | -41.05M | -37.92M | -23.57M | -19.08M | |||
| Income Tax | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | -41.79M | -41.05M | -37.92M | -23.57M | -19.08M | |||
| EBITDA | -46.00M | -46.88M | -44.13M | -24.66M | -16.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.40 | -0.39 | -0.37 | -0.23 | -0.21 | |||
| Non GAAP EPS | -0.40 | -0.39 | -0.37 | -0.23 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.91% | 81.62% | 88.51% | 88.48% | 89.26% | |||
| Profit Margin | -110.92% | -106.29% | -91.85% | -53.25% | -56.30% | |||
| Operating Profit Margin | -133.51% | -132.54% | -116.98% | -61.82% | -53.67% | |||
All data in USD